Clinical Trial

SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma

Name: SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma — clinical trial record (NCT06979986)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is a study from Fujian Cancer Hospital Thoracic of Surgery Project, numbered as FJCHTOSP-1. Systematically mediastinal Lymph Node Dissection (SLD) Versus Non-Dissection Following Endoscopic Submucosal Dissection (ESD) for T1a Stage Esophageal Squamous Cell Carcinoma: a single-center, prospective clinical trial.

Trial Details

NCT Number	NCT06979986
Lead Sponsor	Fujian Cancer Hospital
Conditions	Esophageal Cancer
Enrollment	102 participants
Start Date	2025-06-01
Primary Completion	2027-01-01 (estimated)
Study Completion	2027-04-01 (estimated)
Updated on ClinicalTrials.gov	2025-05-20